Axonics Inc at Bank of America Global Healthcare Conference Transcript
Good morning, everybody, or afternoon, depending on where you are. This is Travis Steed, Bank of America medical device analyst, and up next we have Axonics. We've got Ray Cohen, CEO; and Dan Dearen, CFO. Thanks for joining us.
Ray, maybe just -- I don't know if you had any opening remarks coming out of Q1 that you wanted to touch on or jump into Q&A.
Sure. We're glad most people are starting to have made their deductibles now. So things are looking more, things are looking better.
Questions & Answers
All right. Good. Maybe we'll start with just like thinking through like the progression of Q1, like, I guess, obviously, January is probably down a lot with seasonality. Maybe just think through like how the business is shaping up over the course of Q1 and Q2 momentum into April sequentially what you're seeing on the ground?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |